# IRAPe, Irisin and IL-34 in Patients With Type 2 Diabetes

> **NCT04107259** · — · COMPLETED · sponsor: **Damanhour University** · enrollment: 120 (actual)

## Conditions studied

- Type2 Diabetes Mellitus

## Interventions

- **DIAGNOSTIC_TEST:** Blood sample

## Key facts

- **NCT ID:** NCT04107259
- **Lead sponsor:** Damanhour University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-19
- **Primary completion:** 2019-06-30
- **Final completion:** 2019-07-20
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2020-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04107259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04107259, "IRAPe, Irisin and IL-34 in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04107259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*